sightlife surgical  products mysightlife login order tissue order products our innovative products were committed to developing and bringing products to the market that are designed to help surgeons provide the best possible outcomes for their patients learn more about our innovative products such as the endoserter® the preferred corneal endothelial delivery instrument view our products  services catalog driving medical advancement as we work with a deep sense of urgency to achieve our mission by  sightlife surgical is dedicating resources not previously available to sightlife to invest in new ideas that will transform procedures techniques and patient care  learn more   endoserter® the endoserter® is a sterile singleuse disposable instrument used in dsek procedures its innovative design provides a controlled method of delivering and positioning the donor endothelial allograft into the anterior chamber of the eye during endothelial replacement surgery irrigation may be introduced through the device eliminating the need for a separate chamber maintainer visit order products to watch the instructional video for the endoserter geuder glass cannula for dmek sightlife surgical presents the geuder glass cannula for descemets membrane endothelial keratoplasty dmek procedures gentle smooth atraumatic easy to load large rounded opening of the cannula allowed for simple and easy loading of the graft  mm incision small incision size allows for gentle and controlled injection into anterior chamber visit order products to watch videos of the geuder glass cannula in action donor trephine punch precise accurate controlled sharpest blade ultrathin ultrasharp blade to minimize undercut highest visibility highvisibility guide allows full visualization throughout the process to help accurately center and reposition cornea most control anatomicallycorrect bowl allows cornea to center and stay in positions and finger grips allow for a stable base available with or without vacuum visit order products to get more information regarding the donor trephine punch recipient vacuum trephine sharp accurate strong ultrasharp blade allows for a more vertical cut with reduced undercut industryleading crosshairs designed using military sighting technology enable outstanding positioning and centration allmetal housing provides complete cut control visit order products to get more information regarding the recipient vacuum trephine our services from precisioncut corneal transplant tissue prepared by our skilled technicians to handson surgeon training we’re here to help you provide the best care for your patients learn more tissue services we offer a comprehensive portfolio of corneal transplant tissue processed to the exact standards set by sightlife surgical and within regulations established by the fda and the eye bank association of america learn more imprimis pharmaceuticals and sightlife surgical sign agreement for national launch of serum tears™ imprimis pharmaceuticals and sightlife surgical sign agreement for national launch of serum tears™ imprimis begins rollout of dry eye disease formulary with innovative autologous serum eye drop program news provided by imprimis pharmaceuticals inc  sightlife surgical inc may 0 0  et share this article san diego and seattle may  0 prnewswire  imprimis pharmaceuticals inc nasdaq immy imprimis an ophthalmologyfocused pharmaceutical company and sightlife surgical sightlife surgical a corneafocused organization providing comprehensive services to ophthalmic surgeons announced the signing of an exclusive strategic sales and marketing agreement under the agreement sightlife surgical will deploy their sales team to offer imprimis serum tears™ compounded formulations to physicians large practice groups surgery centers hospitals and healthcare organizations nationwide imprimis serum tears™ autologous serum eye drops aseds are prescribed for chronic dry eye patients who do not respond to traditional dry eye treatments  sightlife surgical patients with dry eye severity typically do not respond to conventional therapy and may be considered candidates for autologous serum eye drops as a treatment option  published data have demonstrated the benefits of using an individuals serum found in their blood which contain antibodies and growth factors as an eye drop therapy for chronic dry eye  under the planned imprimis aseds program serum tears™ will be available in all 0 states in varying ranges of saline dilution combinations  mark l baum ceo of imprimis stated our goals in 0 include the rollout of a formidable array of offerings to compete in the three largest us ophthalmic markets cataract surgery glaucoma and dry eye  we are pleased to have accelerated the first phase of the launch of our dry eye program by partnering with the largest and most prestigious eye bank in the world through this exclusive relationship we expect to reach and serve leading corneal surgeons and their patients whose dry eye conditions may be alleviated with our innovative aseds offering  partnering with sightlife surgical represents an important step in our strategic plan to efficiently expand our sales presence and increase our growing customer base   sightlife surgical provides corneal tissue and medical devices to surgeons around the world who are performing corneal transplant procedures serum tears™ may be used as a preventative treatment of a transplant for patients who suffer from corneal epithelial defects ie abrasions caused by dry eye which makes it a valuable product for the surgeons they serve with the assistance of the imprimis team we intend to train and deploy our sales team on this innovative product for severe dry eye disease said monty montoya president and ceo of sightlife surgical this partnership with imprimis uniquely positions us to help the thousands of domestic physicians treating dry eye and makes this important product widely available to patients in need of these drops across the country imprimis serum tears™ compounded formulations represent a perfect addition to our portfolio and this opportunity aligns with our commitment to bring products to the market that are designed to help ophthalmic surgeons provide the best possible outcomes for their patients  about dry eye disease dry eye is among the most common conditions seen by eye care professionals dry eye occurs when the eye does not produce enough tears or when the tears are not of the correct consistency and evaporate too quickly inflammation of the surface of the eye may also occur dry eye disease also referred to as keratoconjunctivitis sicca kcs dysfunctional tear syndrome lacrimal keratoconjunctivitis evaporative tear deficiency aqueous tear deficiency and lasikinduced neurotrophic epitheliopathy lne can be a temporary or chronic condition causes for dry eye include inflammatory eye conditions postrefractive and other ocular surgery contact lens use decreased hormones associated with aging and numerous other factors an estimated  million ocular surgeries were performed in the us in 0 and over  million americans wear contact lenses it is reported that 0 to  million people suffer from mild dry eye and nine to  million have moderate to severe dry eye although dry eye can impact people of any age elderly people are frequently affected with a reported five million afflicted with ded about sightlife surgical sightlife surgical was founded in fall 0 to challenge the status quo of the cornea ecosystem primarily by driving the systemic change needed to enable innovation and access to treatments for corneal blindness this corneafocused organization provides comprehensive services to support ophthalmic surgeons from corneal tissue and devices to reimbursement consulting and political advocacy based in seattle sightlife surgical is a forprofit subsidiary of sightlife the only nonprofit global health organization working relentlessly to eliminate corneal blindness worldwide by  this missiondriven structure maintains the nonprofit status of sightlife as the parent organization and adds a forprofit engine to power and accelerate achievement of the mission for more information about sightlife surgical please visit wwwsightlifesurgicalcom  about imprimis pharmaceuticals imprimis pharmaceuticals inc nasdaq immy is a pharmaceutical company dedicated to producing and dispensing high quality innovative medications in all 0 states the companys unique business model increases patient access and affordability to many critical medicines headquartered in san diego california imprimis owns and operates three production and dispensing facilities located in california new jersey and pennsylvania for more information about imprimis please visit the corporate website at wwwimprimisrxcom  forwardlooking statements this press release contains forwardlooking statements within the meaning of the us private securities litigation reform act of  any statements in this release that are not historical facts may be considered such forward looking statements forwardlooking statements are based on managements current expectations and are subject to risks and uncertainties which may cause results to differ materially and adversely from the statements contained herein some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to make commercially available our compounded formulations and technologies in a timely manner or at all physician interest in prescribing our formulations risks related to our compounding pharmacy operations our ability to enter into other strategic alliances including arrangements with pharmacies physicians and healthcare organizations for the development and distribution of our formulations our ability to obtain intellectual property protection for our assets our ability to accurately estimate our expenses and cash burn and raise additional funds when necessary risks related to research and development activities the projected size of the potential market for our technologies and formulations unexpected new data safety and technical issues regulatory and market developments impacting compounding pharmacies outsourcing facilities and the pharmaceutical industry competition and market conditions these and additional risks and uncertainties are more fully described in imprimis filings with the securities and exchange commission including its annual report on form 0k and its quarterly reports on form 0q such documents may be read free of charge on the secs web site at wwwsecgov undue reliance should not be placed on forward looking statements which speak only as of the date they are made except as required by law imprimis undertakes no obligation to update any forwardlooking statements to reflect new information events or circumstances after the date they are made or to reflect the occurrence of unanticipated events other than drugs compounded at a registered outsourcing facility all imprimis compounded formulations may only be prescribed pursuant to a physician prescription for an individually identified patient consistent with federal and state laws nodatsuruya t asanokato n toda i  tsubota k autologous serum eye drops for dry eye after lasik j refract surg 00 janfeb retrieved april  0 from httpswwwncbinlmnihgovpubmed kojima t ishida r dogru m goto e matsumoto y kaido m  tsubota k 00 february the effect of autologous serum eyedrops in the treatment of severe dry eye disease a prospective randomized casecontrol study  am j ophthalmol 00 feb retrieved april  0 from httpswwwncbinlmnihgovpubmed mondy p brama t fisher j gemelli c n chee k keegan a  waller d 0 december sustained benefits of autologous serum eye drops on selfreported ocular symptoms and visionrelated quality of life in australian patients with dry eye and corneal epithelial defects transfus apher sci 0 dec doi 00jtransci00 epub 0 nov   retrieved april  0 from httpswwwncbinlmnihgovpubmed market scope report 0 contact lens wearer demographics and risk behaviors for contact lensrelated eye infections — united states 0 0 august  retrieved april 0 0 from httpswwwcdcgovmmwrpreviewmmwrhtmlmmahtm helmer j 0 november 0 dry eyes  surprising causes and treatment retrieved april 0 0 from httpwwwaarporghealthconditionstreatmentsinfo0whatcausesdryeyeshtml sightlife surgical media contacterika novakerikanovaksightlifeorg0 imprimis media contactdeb holliday debpascalecommunicationscom imprimis investor contactbonnie ortegabortegaimprimispharmacom 0   to view the original version on pr newswire visithttpwwwprnewswirecomnewsreleasesimprimispharmaceuticalsandsightlifesurgicalsignagreementfornationallaunchofserumtears0html source imprimis pharmaceuticals inc sightlife surgical inc related links httpwwwimprimisrxcom httpwwwsightlifesurgicalcom my news release contains wide tables view fullscreen you just read imprimis pharmaceuticals and sightlife surgical sign agreement for national launch of serum tears™ news provided by imprimis pharmaceuticals inc  sightlife surgical inc may 0 0  et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search imprimis pharmaceuticals and sightlife surgical sign agreement for national launch of serum tears™  thestreet action alerts plus access aapjim cramers best stocks for 0charitable trust portfoliomost recent trade alert investing rules0 trading commandments real money access rm rules of investingjim cramers best stocks for 00 commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp 00 market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under 0 top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street imprimis pharmaceuticals and sightlife surgical sign agreement for national launch of serum tears™ pr newswire may  0  am edt san diego and seattle may  0 prnewswire  imprimis pharmaceuticals inc nasdaq immy imprimis an ophthalmologyfocused pharmaceutical company and sightlife surgical sightlife surgical a corneafocused organization providing comprehensive services to ophthalmic surgeons announced the signing of an exclusive strategic sales and marketing agreement under the agreement sightlife surgical will deploy their sales team to offer imprimis serum tears™ compounded formulations to physicians large practice groups surgery centers hospitals and healthcare organizations nationwide imprimis serum tears™ autologous serum eye drops aseds are prescribed for chronic dry eye patients who do not respond to traditional dry eye treatments  patients with dry eye severity typically do not respond to conventional therapy and may be considered candidates for autologous serum eye drops as a treatment option  published data  have demonstrated the benefits of using an individuals serum found in their blood which contain antibodies and growth factors as an eye drop therapy for chronic dry eye  under the planned imprimis aseds program serum tears™ will be available in all 0 states in varying ranges of saline dilution combinations  mark l baum ceo of imprimis stated our goals in 0 include the rollout of a formidable array of offerings to compete in the three largest us ophthalmic markets cataract surgery glaucoma and dry eye  we are pleased to have accelerated the first phase of the launch of our dry eye program by partnering with the largest and most prestigious eye bank in the world through this exclusive relationship we expect to reach and serve leading corneal surgeons and their patients whose dry eye conditions may be alleviated with our innovative aseds offering  partnering with sightlife surgical represents an important step in our strategic plan to efficiently expand our sales presence and increase our growing customer base   sightlife surgical provides corneal tissue and medical devices to surgeons around the world who are performing corneal transplant procedures serum tears™ may be used as a preventative treatment of a transplant for patients who suffer from corneal epithelial defects ie abrasions caused by dry eye which makes it a valuable product for the surgeons they serve if you liked this article you might like epipen price relief could come from rivals before politicians mylans epipen continues to dominate the market as a onetime rival looks to come back anders keitz sep  0 0 pm edt relief from epipens stranglehold may come from rivals before politicians mylans epipen continues to dominate the market as a onetime rival looks to come back anders keitz sep  0  pm edt these  under0 stocks are set to soar higher these under0 stocks look poised to break out and trade higher from current levels roberto pedone mar  0 00 am edt these  stocks under 0 are set to soar higher when a stock makes a largepercentage move it is often just the start of a new major trend  a trend that can lead to huge profits roberto pedone mar  0  am edt trending amazon and general electric are fridays smoking hot tickers amzn tsla sbux ge aapl here is why jim cramer doesnt want to buy more starbucks shares for action alerts plus amazon and starbucks team up to take down nasdaq apple investing billions in oled display buy chevron exxon mobil on solid dividends chart pinpoints when to load advertising partners 0 thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers sightlife surgical inc company profile  bloomberg feedback sightlife surgical inc private company company profile sector health care industry health care facilities  svcs subindustry health care services sightlife surgical inc was founded in 0 the companys line of business includes providing health and allied services corporate information address 00 th ave ste 0 seattle wa united states phone  fax  from the web key executives monty montoya presidentceo p bernard haffey bernie chief commercial officer sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data sightlife surgical  our people mysightlife login order tissue order products our people board of directors board member richard lindstrom md board member richard lindstrom md dr lindstrom is the founder and attending surgeon at minnesota eye consultants adjunct clinic professor emeritus at the university of minnesota department of ophthalmology and visiting professor at the uc irvine gavin herbert eye institute  dick is a boardcertified ophthalmologist and internationally recognized leader in corneal cataract refractive glaucoma and laser surgery he has been at the forefront of ophthalmologys evolutionary changes throughout his career as a recognized researcher teacher inventor writer lecturer and highly acclaimed physician and surgeon after graduating magna cum laude from the college of liberal arts at the university of minnesota dick completed his doctorate degree in medicine in  he has been awarded over  patents in ophthalmology and has developed a number of corneal preservation solutions intraocular lenses and instruments that are used in clinical practices globally  he is the recipient of numerous awards for distinguished service by national and international ophthalmology associations including the lans barraquer and the first lifetime achievement award from the international society of refractive surgery board chair william link phd board chair william link phd dr link is a leader in the healthcare industry he is a managing director of versant ventures a leading venture capital firm focused in healthcare at versant bill has specialized in earlystage investing in medical devices with more than two decades of operations experience in the healthcare industry he has a proven record of building and managing large successful medical product companies prior to entering venture capital bill founded two companies which still today are leaders in the field of surgical ophthalmology in  bill founded and served as chairman and ceo of chiron vision a subsidiary of chiron corporation specializing in ophthalmic surgical products prior to chiron vision bill founded and served as president of american medical optics a division of american hospital supply corporation before entering the healthcare industry bill was an assistant professor in the department of surgery at the indiana university school of medicine bill received his bs ms and phd in mechanical engineering from purdue university president  ceo monty montoya president  ceo monty montoya monty montoya pursues the worldwide elimination of corneal blindness by  with a passion for those in the global arena of corneal transplantation and eye banking he is considered a true social humanitarian for working tirelessly to achieve that mission for the past 0 years   as ceo of sightlife surgical as well as its nonprofit parent company sightlife monty is dedicated to transforming the cornea ecosystem by driving innovations in research products prevention and policy to help the 0 million living with treatable corneal blindness   monty joined sightlife in  when he was hired to turn the organization around from a period of financial struggle under his determined leadership sightlifes growth has scaled from a modest  million to more than  million in 0 years with nearly 0 million reinvested back into sightrelated programs for lowincome populations domestically and abroad   he has been honored with prestigious awards for his vision and service including the ernst  young 0 entrepreneur of the year award in the pacific northwest life sciences category and the eye bank association of americas coveted heise award this award is given to a nonmedical individual who has made the greatest contribution to advancing the cause of eye banking   monty holds a bachelors degree from arizona state university and an mba from duke university board member kush g parikh board member kush g parikh kush parikh is north america president and chief product officer of the internet and mobile division of paypoint a publicly traded company on the london stock exchange kush contributes business and strategic acumen to sightlife surgical helping to stage growth as our organization accelerates its mission to eliminate corneal blindness worldwide  kush previously worked in corporate development at texas instruments where he helped apply cuttingedge semiconductor technology to various medical devices including hearing aids and portable defibrillators more recently he was also senior vice president and general manager of inrix a company he helped build from  employees and no customers in 00 to one with more than 0 employees and scores of customers by 0  kush holds a bs in electrical engineering from penn state university and an mba in financeentrepreneurship from duke university’s fuqua school of business   board member melody j summers board member melody j summers melody summers joined the sightlife surgical board of directors in 00 she is the national recruiting managing director of alvarez  marsal taxand llc advising a broad client base in the real estate financial services agricultural mining and manufacturing industries prior to joining am melody had a year career with accounting firms in san francisco most recently she served as director of finance with a private equity firm  melody earned a bachelors degree in managerial and agricultural economics from the university of california at davis and a juris doctor from santa clara university school of law she is a member of the state bar of california and the american bar association executives president  ceo monty montoya president  ceo monty montoya monty montoya pursues the worldwide elimination of corneal blindness by  with a passion for those in the global arena of corneal transplantation and eye banking he is considered a true social humanitarian for working tirelessly to achieve that mission for the past 0 years as ceo of sightlife surgical as well as its nonprofit parent company sightlife monty is dedicated to transforming the cornea ecosystem by driving innovations in research products prevention and policy to help the 0 million living with treatable corneal blindness   monty joined sightlife in  when he was hired to turn the organization around from a period of financial struggle under his determined leadership sightlifes growth has scaled from a modest  million to more than  million in 0 years with nearly 0 million reinvested back into sightrelated programs for lowincome populations domestically and abroad he has been honored with prestigious awards for his vision and service including the ernst  young 0 entrepreneur of the year award in the pacific northwest life sciences category and the eye bank association of americas coveted heise award this award is given to a nonmedical individual who has made the greatest contribution to advancing the cause of eye banking   monty holds a bachelors degree from arizona state university and an mba from duke university   chief commercial officer bernie haffey chief commercial officer bernie haffey bernie joined sightlife surgical in may 0 as chief commercial officer using his extensive background launching emerging medical technology companies bernie oversees sales marketing business development and product development most recently bernie was president of 00 management consulting inc a firm he founded to assist organizations in high performance management system hpms adoption previously bernie served as president and ceo of nexis vision and president and ceo of ndo surgical inc earlier bernie also served as executive vice president and chief commercial officer at summit technology inc and intralase corp both achieving 00m in revenue and  b exits under his management he previously also held executive management positions at mentor corp and in hewlett packard company’s medical products group  bernie has served on the founding boards of several successful medical device companies he earned a bachelor’s degree from colgate university and an mba from cornell university chief operating officer bernie iliakis chief operating officer bernie iliakis bernie is the longest tenured employee of sightlife joining the organization in july  he is responsible for all sightlife eye bank operations including all the people and activities involved in the donation process and the flow of ocular tissue in and out of the organization bernie has been directly or indirectly involved in more than 0 over  of the corneal tissues provided for transplant by sightlife since  for the eye bank association of america ebaa bernie serves on the medical advisory board which creates and revises the medical standards that govern eye banking and as an inspector on the accreditation board which determines ebaa accreditation status of eye banks bernie is a member of the american association of ophthalmology and american society of cataract and refractive surgery course faculty for femtosecond laser keratoplasty  bernie received his master’s degree in health administration from the university of washington and graduated cum laude with a bachelor of science in zoology also at the uw chief financial officer tim mclaughlin chief financial officer tim mclaughlin tim joined sightlife in april 00 after holding positions as cfo for eddie bauer vice presidentcontroller for att wireless services and cfo of national cash register corporation’s microelectronics division  his financial leadership has helped sightlife to a period of rapid growth the operational budget more than tripled from  million when tim started in 00 to  million for 0 while employee count grew from  to 0 tims ability to manage this growth while maintaining sure financial footing has enabled sightlife to add 0 global eye bank projects over the last two years while adding over  million to operating reserves in addition to financial matters tim is responsible for human resources risk management information technology facilities and purchasing at sightlife tim graduated from wake forest university with a bachelor of science degree in business administration and earned his mba in finance at northwest missouri state university   chief sales officer jerry barker chief sales officer jerry barker jerry has more than a decade of laboratory experience and technical expertise in eye banking including six years as director of clinical services at the north carolina eye bank  during his tenure at the north carolina eye bank jerry’s multidisciplinary team of specialists worked with surgeons pharmaceutical companies researchers and bioinformatics firms to maximize use of scarce donor tissue he led a team that collaborated with surgeons and researchers using the intralase fs™ laser to investigate and develop innovative uses of allografts he has broad experience with physician relations regulatory affairs quality control procedures voluntary medical standards and applicable state and federal regulations jerry has a bs in biology with chemistry minor from cumberland college in williamsburg ky he is an ebaa certified eye bank technician and an emergency medical technician emtfirefighter he also completed the leadership development program at the center for creative leadership in greensboro nc chief talent management officer gretchen coker chief talent management officer gretchen coker gretchen came to sightlife in 00 with more than 0 years of human resources experience  with previous roles at companies such as starbucks and doubletree hotels gretchen is an expert in supporting and setting corporate office policy employee benefits and relations as well as supporting international operations and development gretchen received a bachelor of arts in music from the university of washington and a master’s of science in human resources management from chapman university in california she is certified in both phr and sphr  chief marketing officer rusty kelly chief marketing officer rusty kelly rusty joined sightlife in 00 with leadership credentials burnished from eight years as vice president of the eye bank association of america rusty also doubled as communications director for the ebaa in his first two years at sightlife as california regional director he led a team effort that more than doubled the number of corneas recovered at hospitals in that service area rusty was promoted to chief marketing officer in january 0 to help grow partnerships with surgeons and healthcare organizations domestically and in the developing world rustys previous service to advance eye banking includes cofounding the cornea collaborative that increased the quality and quantity of corneas for transplant in the united states he also served on the board of directors for donate life america and advised and worked in numerous campaigns to increase state donor registries rusty received his bachelor’s degree from state university of new york geneseo senior advisor to the ceo sandy jeghers senior advisor to the ceo sandy jeghers sandy jeghers has more than  years’ experience in healthcare executive management and business development he is the former president and chief executive officer of overlake hospital medical center in bellevue wa  sandy was recruited to sightlife in 00 after serving on its board of trustees and was sightlife’s chief marketing officer until 0 he has a long history of marketing in the healthcare field as a senior consultant for a major national accounting firm and as a speaker for the american college of healthcare executives ache where he is currently a diplomat  sandy has an mba from george washington university and received his certification in gerontology from the university of washington sandy has a particular interest in the field of organ and tissue transplantation with specific focus on the global health implications of eliminating corneal blindness    executive john gukes executive john gukes john w guckes joined sightlife surgical in july 0 as senior advisor to the ceo and executive team he is also an independent consultant to the ophthalmic industry and has worked with sightlife in this capacity for the past three years john is a former executive with bausch  lomb rochester ny during his more than year career there he served in a variety of senior leadership positions including vice president global cataract strategy vice president global cataract and vitreoretinal equipment vice president and general manager global instruments and vice president asia pacific commercial operations john is recognized for his integrity and strong strategic and tactical leadership for initiating and growing global businesses and the development and mentoring of ophthalmic business leaders throughout the world he is a board member of the eye bank association of america the life long vision foundation and the university of missourist louis’ internationally recognized global business institute john holds a bachelor of arts degree magna cum laude and masters in business administration both from the university of missourist louis medical directors associate medical director michael banitt md associate medical director michael banitt md region northwest dr banitt is originally from the midwest he is an associate professor of ophthalmology he completed his ophthalmology training at the new york eye and ear infirmary in new york city later became subspecialty trained in cornea and external diseases at the university of michigan and then glaucoma at the university of miami he is board certified by the american board of ophthalmology in 00 he is a member of the american academy of ophthalmology his research interests are of clinical trials in the area of cornea and glaucoma his goal is to find better surgeries to improve people’s sight undergraduate educationbs biology st louis university  ba chemistry st louis university  medical school md wayne state university school of medicine 00 post graduate education master health administration st louis university of public health  internship internal medicine beth israel medical center 00 residency ophthalmology new york eye and ear infirmary 00 fellowship cornea and external disease kellogg eye institute 0 glaucoma bascom palmer eye institute 00 associate medical director harry w buchanan iv md associate medical director harry w buchanan iv md region northeast dr buchanan graduated from university of virginia school of medicine in  and served his ophthalmology residency training at the vanderbilt university medical center and fellowships at both wills eye hospital pa and moorfields eye hospital in london harry is an ophthalmologist for lehigh valley health network and specializes in external eye diseases he has more than  years’ experience and has served as a medical director for the northeast pennsylvania lions eye bank for more than  years associate medical director david a derose md associate medical director david a derose md region northeast dr derose received his bachelor of science degree in biochemistry at the university of rochester and obtained his medical degree from the hahnemann university school of medicine he joined lehigh eye specialists after serving patients in northeast pennsylvania for more than a decade david specializes in the medical and surgical treatment of anterior segment abnormalities including corneal edema and scarring keratoconus refractive abnormalities glaucoma dry eye syndrome and complicated cataracts david performs penetrating keratoplasty dsek lasik prk glaucoma surgery and smallincision phacoemulsification for cataract surgery he has been a medical director at the northeast pennsylvania lions eye bank since 0 associate medical director marjan farid md associate medical director marjan farid md region california dr farid joined sightlife’s board of directors in 0 as an associate medical director she holds a number of positions at the university of californiairvine ophthalmology school of medicine including associate clinical professor director of cornea cataract and refractive surgery in the ocular surface disease program and vice chair of ophthalmic faculty marjan received her medical degree from the university of california san diego she is a member of several ophthalmic societies including the american association of ophthalmology ophthalmic women leaders and the orange county cornea society of ophthalmology associate medical director sumit sam garg md associate medical director sumit sam garg md region california dr garg joined sightlife’s board of directors in 0 as an associate medical director he is the assistant professor of ophthalmology for cataract external diseasecorneal surgery and refractive surgery at the university of californiairvine ophthalmology school of medicine sam is also a medical director at the gavin herbert eye institute and vicechair of clinical ophthalmology at the institute’s school of medicine sam received his medical degree from new york medical college in valhalla ny he is a member of several ophthalmic societies including the american association of ophthalmology the american society of cataract and refractive surgery and the association for research in vision and ophthalmology associate medical director matthew giegengack md associate medical director matthew giegengack md region southeast dr giegengack completed his undergraduate degree at yale university he taught high school physics for three years in washington dc before attending medical school at columbia university college of physicians and surgeons he completed his ophthalmology residency and fellowship at the casey eye institute in portland or matthew joined the faculty at wake forest university school of medicine in 00 over the past nine years he has become one of the busiest cornea transplant surgeons in north carolina  he has been performing dsek surgery for the entirety of his career and has transitioned to dmek for appropriate cases for the past two years he is also experienced with pk dalk and kpro matthew is currently an associate professor at wake forest university eye center and is codirector of the wake forest cornea fellowship program he directs the wake forest eye center global outreach program and has made two trips to honduras to perform cataract and cornea surgery he’s also involved in sightlife’s global outreach mission associate medical director neil b griffin md associate medical director neil b griffin md region southeast dr griffin specializes in cataract refractive surgery lasik surgery and corneal diseases neil is a pioneer in endokeratoplasty a new type of corneal transplantation technique he has presented study results and his technique to surgeons in both the united states and abroad as an ophthalmologist leader in the field he continues to instruct corneal surgeons on the latest advancements he received his medical degree from the university of alabama school of medicine where he was elected to the alpha omega alpha honor medical society he served his internship at the mayo clinic in rochester mn and completed his residency at the university of maryland neil received his highly specialized fellowship in cornea and external disease from the university of texas he is board certified by the american board of ophthalmology and is also a member of the american academy of ophthalmology associate medical director douglas holsclaw md associate medical director douglas holsclaw md region california dr holsclaw has served as an associate medical director at sightlife since 00 he is the director of the cornea and external disease service at the kaiser permanente medical group in redwood city ca and serves as director for northern california kaiser permanente doug holds ancillary positions at the university of california san francisco leading subspecialty clinics and teaching and training the next generation of cornea surgeons he actively participates in the training of international cornea fellows and is involved with research and clinical efforts to prevent and treat corneal blindness in the developing world doug received his medical degree from columbia university and is a member of several professional societies including the american association of ophthalmology the american society of cataract and refractive surgery and the association for research in vision and ophthalmology   associate medical director bennie h jeng md ms associate medical director bennie h jeng md ms region at large bennie joined sightlife’s board of directors in 0 as an associate medical director he is the chair of the department of ophthalmology and visual sciences at the university of maryland associate medical director terry kim md associate medical director terry kim md region southeast dr kim professor of ophthalmology at duke university eye center received his medical degree from duke university school of medicine and completed his residency and chief residency in ophthalmology at emory eye center he continued with his fellowship training in cornea external disease and refractive surgery at wills eye hospital he was then recruited to duke university eye center where he serves as principal and coinvestigator on a number of research grants from the national institutes of health and other industry sponsors   his academic accomplishments include more than 0 peerreviewed journal articles textbook chapters and scientific abstracts his clinical and research work has earned him honors and grants from the american academy of ophthalmology aao national institutes of health fight for sightresearch to prevent blindness the heed ophthalmic foundation alcon laboratories and allergan terry serves on the executive committee of the american society of cataract and refractive surgery ascrs the annual program committee of the aao and the executive committee and board of directors of the cornea society he also serves as consultant to the ophthalmic devices panel of the fda and consultant to numerous ophthalmic companies associate medical director alan b leahey md associate medical director alan b leahey md region northeast dr leahey the chief of ophthalmology at greenville health system has been performing refractive surgery since  he practiced ophthalmology in allentown pa from  to june 0 before joining the greenville health system  alan is the former associate chief of ophthalmology at lehigh valley hospital and a former clinical associate in ophthalmology at the university of pennsylvania school of medicine he performed the first prk and the first conventional lasik in the lehigh valley area of pennsylvania in addition to refractive surgery alan specializes in cataract and intraocular lens surgery along with cornea and conjunctival surgery he received his medical degree from georgetown university school of medicine and has served as a medical director on behalf of the northeast pennsylvania lions eye bank for the past  years associate medical director matthew s oliva md associate medical director matthew s oliva md region northwest dr oliva has served as an associate medical director at sightlife since 00 his private practice in ophthalmology specializing in cornea and external diseases and refractive surgery is at the medical eye center in medford or  matt currently serves as a board member on the himalayan cataract project a nonprofit ngo operating in asia and africa to eliminate treatable blindness through the provision of eye surgery training physicians and the development of worldclass eye care infrastructure  he obtained his doctor in medicine with honors from the university of washington’s school of medicine and was awarded the university of washington school of medicine humanitarian award in 0 associate medical director rey torres pangilinan md associate medical director rey torres pangilinan md region california dr pangilinan joined sightlife as an associate medical director in 0 his practice at kaiser permanente in los angeles ca consists of comprehensive ophthalmology as well as addressing problems with cornea external disease and refractive surgery  he participates in annual medical missions to fiji and the philippines and is a clinical assistant professor of ophthalmology at the university of southern california’s keck school of medicine rey received his medical degree from west virginia university in morgantown wv   associate medical director audrey talleyrostov md associate medical director audrey talleyrostov md region international dr talleyrostov md is a partner at northwest eye surgeons she is a cornea cataract and refractive surgeon specializing in complex anterior segment management audrey completed her preclinical medical education at harvard medical school and a research fellowship in ophthalmology at massachusetts eye and ear infirmary before receiving her md from washington university in st louis after interning at ucsf she completed her residency in ophthalmology at washington university and then served as a heed fellow with dr richard lindstrom in minnesota she has extensive experience with presbyopic correcting iols participating in several clinical trials including synchrony and tecnis iols and was one of the first crystalens surgeons she is currently an investigator with clinical trials for collagen crosslinking for keratoconus and does clinical research on femtosecond laser keratoplasty techniques she was the first surgeon to perform and teach femtosecond laser keratoplasty in new delhi india she was a 0 recipient of the millennial eye outstanding female ophthalmologist award and has also received an american academy of ophthalmology aao senior achievement award and an aao award for outstanding contributions to the cornea preferred practice patterns committee associate medical director keith a walter md associate medical director keith a walter md region southeast dr walter completed his undergraduate degree at the university of california davis and received his medical training at duke university he completed his ophthalmology residency and fellowship at emory university  during his fellowship he was a coinvestigator of the first and largest lasik investigation in the united states and has been performing lasik since  keith joined the faculty at wake forest university school of medicine in  keith is currently professor at wake forest university eye center  he has published extensively and presented several peerreviewed papers in ophthalmology including a recent publication on automated endothelial keratoplasty he has received numerous honors most recently receiving the spark award for innovating surgical tool development in 0 at wake forest keith is an inventor and holds more that six patents on ophthalmic surgical tools including his patent on the endoserter® a corneal endothelial delivery instrument which gained fda approval in 0 medical advisory board test role test person test role test person this is an example biography vice presidents vp of operations northeast michael bearden vp of operations northeast michael bearden vp of clinical service caroline hoover vp of clinical service caroline hoover caroline hoover cebt has evaluated more than  corneas on the slit lamp microscope over her tenure with sightlife caroline joined sightlife in 00 as an eye recovery technician she gained further experience as an eye bank coordinator before joining the distribution department as a coordinator in 00 she was promoted to distribution manager in 00 and then again to director of clinical services in 0 she was made vice president in 0 her unparalleled commitment to ensuring that every surgeon obtain the highest quality corneal tissue has helped sightlife achieve a  success rate in filling scheduled requests from surgeons and a  ontime delivery rate carolines contributions to advancement of eye banking include service on the eye bank advisory committee for the cornea preservation time study committed to ensuring the most efficient distribution systems all over the world she has also traveled to india to train surgeons at a global medical advisory meeting in slit lamp evaluation  caroline graduated from the university of washington with a bs in cell and molecular biology vp of operations california drew maxwell vp of operations california drew maxwell drew became vice president of operations california in 0 after more than a decade at sightlife’s seattle headquarters   during his time in seattle drew directly helped deliver the gift of sight to  corneal transplant recipients while serving in nearly every job capacity in the organization he joined sightlife in 00 as a recovery technician then as an eye bank coordinator responsible for counseling families about the option of cornea donation he facilitated  recoveries that resulted in  transplants  drew also served in the quality assurance department during a time of rapid change in eye banking technology and compliance requirements and as medical review manager from 00 to 0 vp of quality assurance and regulatory affairs tom miller vp of quality assurance and regulatory affairs tom miller sightlife surgical  home mysightlife login order tissue order products introducing sightlife surgical as a new subsidiary of sightlife we’re accelerating our shared mission to eliminate treatable corneal blindness worldwide by  we’re driving innovations in research products therapeutics prevention and policy to transform the corneal ecosystem learn more we serve as a global leader and partner to eliminate corneal blindness worldwide by   order tissue we are the largest provider of corneal tissue for transplant in the world sightlife surgical’s skilled technicians have processed more than  corneas and we offer a comprehensive selection of the highest quality tissue get started order products from the innovative endoserter to the new cannula for dmek we are committed to developing and bringing products to the market that are designed to help surgeons provide the best possible outcomes for their patients discover the cannula i have a longstanding relationship with this team and my expectations have been exceeded each and every time i receive tissue terry kim md professor of ophthalmology duke university eye center discover our services view our catalog of surgical services from precisioncut corneal transplant tissue and easy online ordering to reimbursement assistance and surgeon training   learn more dmek webinar take dmek to the next level tips tricks and pearls on increasing or efficiency  and decreasing time during dmek surgeries presented by ravi patel md august  0 at pm pdt   edt register now our commitments previous medical advancementwe’re committed to leading research efforts and developing new technologies for innovative and affordable therapeutics that will transform the medical care available for those living with corneal blindness learn more reimbursement  policywe’re committed to removing systemic barriers that limit patients’ access to care and surgeons’ ability to provide the best corneal treatments to their patients learn more prevention  treatmentwe’re committed to significantly increasing prevention and early treatment solutions which are critical to eliminating corneal blindness by  learn more next join our team headquartered in seattle wa and with offices in california and the northeast and southeast us sightlife surgical provides an engaging purposefilled work environment where youll find opportunities for both personal and professional growth learn more news and information sightlife closes series a financing sightlife announced on 0 that it has raised 0 million in series a financing from flying l partners william link phd’s new healthcare investment firm this investment will fund sightlife’s creation of sightlife surgical a forprofit subsidiary of the seattlebased global health organization read more how to get reimbursement assistance sightlife surgical is pleased to provide its customers with reimbursement consulting to help guide you in billing corneal tissue to your local medicare carrier and other commercial insurance carriers read more sightlife surgical  medical advancement mysightlife login order tissue order products medical advancement todays research tomorrows innovations were continually innovating to bring the latest most advanced therapeutics for treating corneal blindness to you and your patients learn more about our efforts in prevention and early treatment promising innovations to have the greatest impact we’re committed to leading research that helps us identify the most pressing needs and challenge the status quo of treatment for corneal blindness below are a few of our efforts currently underway advancing corneal therapies injectable endothelial cell therapy in development by professor shigeru kinoshita is a great example of a promising innovation dr kinoshita and his team of partners are culturing human corneal endothelial cells and injecting them into the anterior chamber   increasing the imaging of corneal tissue to maximize every gift of sight  we are working with researchers to improve the current methods of imaging corneal endothelial cells when cells are easier to visualize we can ensure a precious gift of sight is not needlessly discarded increasing the safety of tissue transplanted we are researching methods for providing additives to the solutions in which corneas are placed in order to remove organisms that could cause disease watch for updates as we continue our efforts to advance cornea treatments for help with your ideas and cornea related projects contact us to start the conversation